Ignite Creation Date:
2024-05-05 @ 9:47 PM
Last Modification Date:
2024-10-26 @ 10:09 AM
Study NCT ID:
NCT00967330
Status:
COMPLETED
Last Update Posted:
2015-11-20
First Post:
2009-06-16
Brief Title:
A Study of Avastin Bevacizumab and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Organization Data
Organization:
Hoffmann-La Roche
Class:
INDUSTRY
Study ID:
ML21965
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hoffmann-La Roche
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None